CDRH PMA Review Performance Improves In FY 2000 Wrap-Up
This article was originally published in The Gray Sheet
Executive Summary
FDA's average review time for PMAs in fiscal year 2000 dropped to 8.1 months, a decrease of approximately one month compared to the previous year.
You may also be interested in...
ODE Recounts Review Times In Device Center's FY 2000 Annual Report
Average total time elapsed for PMA reviews decreased to 11.9 months in fiscal year 2000, according to the FY 2000 Center for Devices and Radiological Health annual report.
ODE Recounts Review Times In Device Center's FY 2000 Annual Report
Average total time elapsed for PMA reviews decreased to 11.9 months in fiscal year 2000, according to the FY 2000 Center for Devices and Radiological Health annual report.
Ongoing FDA Modernization Is Focus Of AdvaMed 2001 Legislative Spotlight
A congressional hearing tentatively scheduled to take place by mid-2001 will examine the ability of FDA to approve breakthrough medical technology in a timely fashion, according to the medical device trade group AdvaMed.